Page 259 - Multidisipliner Covid 19

COVID-19 Afl› Platformlar› ve Güncel Afl› Gelifltirme Çal›flmalar›

challenge with the SARS virus. PLoS One. 2012;7(4). doi:10.1371/journal.
pone.0035421
34. Iwata-Yoshikawa N, Uda A, Suzuki T, et al. Effects of Toll-Like Receptor
Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice
Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-
Related Coronavirus Vaccine. J Virol. 2014;88(15):8597-8614. doi:10.
1128/jvi.00983-14
35. Bolles M, Deming D, Long K, et al. A Double-Inactivated Severe Acute
Respiratory Syndrome Coronavirus Vaccine Provides Incomplete
Protection in Mice and Induces Increased Eosinophilic Proinflammatory
Pulmonary Response upon Challenge. J Virol. 2011;85(23):12201-12215.
doi:10.1128/jvi.06048-11
36. Wang Q, Zhang L, Kuwahara K, et al. Immunodominant SARS coro-
navirus epitopes in humans elicited both enhancing and neutralizing
effects on infection in non-human primates. ACS Infect Dis.2016;2(5):
361-376. doi:10.1021/acsinfecdis.6b00006
37. Yasui F, Kai C, Kitabatake M, et al. Prior Immunization with Severe
Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-
CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected
with SARS-CoV. J Immunol. 2008;181(9):6337-6348. doi:10.4049/
jimmunol.181.9.6337
38. Agrawal AS, Tao X, Algaissi A, et al. Immunization with inactivated
Middle East Respiratory Syndrome coronavirus vaccine leads to lung
immunopathology on challenge with live virus. Hum Vaccines Immu-
nother. 2016;12(9):2351-2356. doi:10.1080/21645515.2016.1177688
39. Quinlan BD, Mou H, Zhang L, et al. The SARS-CoV-2 receptor-binding
domain elicits a potent neutralizing response without antibody-de
pendent enhancement. bioRxiv. April 2020:2020.04.10.036418. doi:10.
1101/2020.04.10.036418
40. Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy
in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117(17):9490-
9496. doi:10.1073/pnas.2004168117
41. Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on
immune responses. Cell Death Differ. 2020;27(5):1451-1454. doi:10.1038/
s41418-020-0530-3
42. Lv H, Wu NC, Mok CKP. COVID_19 vaccines: knowing the unknown.
Eur J Immunol. May 2020:eji.202048663. doi:10.1002/eji.202048663

258